A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM

Inclusion Criteria: * Patients with diagnosis of T2DM for \> 1 year prior to entry in the study willing and able to complete the questionnaire and on pharmacotherapy * Patients who are currently treated with a single or combination of injectable/oral antidiabetic drugs with or without insulin therapy * Treatment type must be unchanged in the previous 3 months. However, dose modifications are allowed * Patients who agree to participate in the study and give their written informed consent Exclusion Criteria: * Patients with type 1 diabetes * Patients with diabetic ketoacidosis and/or hyperosmolar hyperglycaemic state * Patients with secondary diabetes (including disease of the exocrine pancreas, endocrinopathies) * Patients with concurrent treatment involving systemic glucocorticoids. However, inhaled, locally injected and topical use of glucocorticoids is allowed * Patients suffering from severe cardiac, hepatic, renal diseases as judged by the investigator * Any condition of the patient which may have an impact on objective and outcome of the trial example: patients currently undergoing major/ minor surgical